ACTIVE

PHARMA MANUFACTURING

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

2,4 k €

-83.5% YoY

Revenue

2,8 M €

-4.4% YoY

Equity

2,8 M €

+0.1% YoY

Workforce

9,6 ETP

+4.3% YoY

What does PHARMA MANUFACTURING do?

PHARMA MANUFACTURING is a Public limited company incorporated in 2001. Its main activity is: Manufacture of homogenised food preparations and dietetic food. Its registered office is in Gembloux. It employs on average 9,6 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0475.313.955

Incorporation

16/07/2001

Legal form

Public limited company

Registered office

Rue Guillaume Fouquet,Isnes 16
5032 Gembloux · WallonieSee on map

Contributed capital

62 000,00 €

Latest accounts

31/12/2024

Average workforce

9,6 ETP

Activities (NACE)

10860Manufacture of homogenised food preparations and dietetic food· main 10860Manufacture of homogenised food preparations and dietetic food 15880Manufacture of leather and related products 74820Other professional, scientific and technical activities 82920Packaging activities 82920Packaging activities+3

Joint committees (5)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	2,8 M €	-4.4%	2,9 M €	-0.2%	2,9 M €	+2.8%	2,8 M €	-10.2%	3,2 M €		0 €		–		–		–		–		–		–		–		–		–		970,6 k €		–		618,7 k €	+16.4%	531,3 k €
EBITDA	179,1 k €	-25.4%	240,3 k €	-54.5%	527,7 k €	+1846%	-30,2 k €	-107%	425,4 k €	-16.4%	508,9 k €	+39.0%	366 k €	+45.6%	251,3 k €	-46.4%	468,5 k €	-29.5%	664,5 k €	-7.6%	718,8 k €	+2.0%	705 k €	+31.0%	538 k €	-19.8%	670,5 k €	+89.7%	353,4 k €	+55.5%	227,3 k €	-11.2%	255,8 k €	+24.8%	205 k €	+175%	74,5 k €
Operating result	6,8 k €	-68.2%	21,3 k €	-94.5%	390,7 k €	+341%	-162 k €	-154%	299,9 k €	-15.8%	355,9 k €	+60.3%	222,1 k €	+157%	86,3 k €	-73.6%	326,4 k €	-36.3%	512,3 k €	-6.5%	547,7 k €	+3.0%	531,8 k €	+57.4%	337,8 k €	-28.4%	471,9 k €	+155%	185,2 k €	+238%	54,7 k €	-35.0%	84,2 k €	+28.4%	65,6 k €	+235%	-48,7 k €
Net result	2,4 k €	-83.5%	14,3 k €	-95.8%	338,1 k €	+308%	-162,9 k €	-172%	227,1 k €	-8.6%	248,3 k €	+62.1%	153,2 k €	+173%	56,2 k €	-76.5%	239,4 k €	-27.7%	331 k €	-6.3%	353,2 k €	+5.8%	333,8 k €	+54.8%	215,7 k €	-23.8%	282,9 k €	+157%	110,2 k €	+2425%	4,4 k €	-87.6%	35,3 k €	+5.2%	33,5 k €	+128%	-118,7 k €
Balance sheet
Equity	2,8 M €	+0.1%	2,8 M €	+0.5%	2,7 M €	+14.1%	2,4 M €	-6.4%	2,6 M €	+9.7%	2,3 M €	+11.9%	2,1 M €	+7.9%	1,9 M €	+2.8%	1,9 M €	+14.9%	1,6 M €	+25.3%	1,3 M €	+37.0%	954 k €	+53.8%	620,2 k €	+53.3%	404,5 k €	+233%	121,6 k €	+966%	11,4 k €	+62.0%	7 k €	+125%	-28,3 k €	+54.3%	-61,8 k €
Total assets	3 M €	+0.0%	3 M €	+3.1%	2,9 M €	+9.5%	2,7 M €	-7.5%	2,9 M €	+3.3%	2,8 M €	+6.5%	2,6 M €	+5.9%	2,5 M €	-4.8%	2,6 M €	+5.1%	2,5 M €	+0.6%	2,5 M €	+16.8%	2,1 M €	+19.4%	1,8 M €	-7.8%	1,9 M €	+4.1%	1,8 M €	-5.1%	1,9 M €	-6.8%	2,1 M €	+6.7%	1,9 M €	+1.5%	1,9 M €
Cash	38 k €	-30.6%	54,7 k €	-50.6%	110,9 k €	-16.0%	132 k €	-2.5%	135,4 k €	-41.5%	231,2 k €	+13.7%	203,4 k €	+135%	86,5 k €	-22.7%	111,8 k €	-28.2%	155,8 k €	+63.0%	95,6 k €	+116%	44,2 k €	-16.4%	52,9 k €	-62.7%	141,6 k €	+167%	53,1 k €	+4.7%	50,7 k €	-63.3%	138,3 k €	+496%	23,2 k €	+113%	10,9 k €
Debts	252,4 k €	-0.8%	254,3 k €	+43.0%	177,8 k €	-32.4%	263,1 k €	-16.4%	314,7 k €	-29.9%	448,6 k €	-15.0%	527,6 k €	-1.2%	534,2 k €	-24.8%	710,7 k €	-14.2%	828,4 k €	-27.7%	1,1 M €	+0.0%	1,1 M €	+0.8%	1,1 M €	-24.3%	1,5 M €	-12.2%	1,7 M €	-10.5%	1,9 M €	-7.1%	2,1 M €	+4.9%	2 M €	-0.2%	2 M €
Other
Workforce	9,6 ETP	+4.3%	9,2 ETP	-5.2%	9,7 ETP	+4.3%	9,3 ETP	-2.1%	9,5 ETP	+15.9%	8,2 ETP	+28.1%	6,4 ETP	+10.3%	5,8 ETP	-6.5%	6,2 ETP	0.0%	6,2 ETP	+10.7%	5,6 ETP	-15.2%	6,6 ETP	+1.5%	6,5 ETP	0.0%	6,5 ETP	+18.2%	5,5 ETP	-20.3%	6,9 ETP	+35.3%	5,1 ETP	+34.2%	3,8 ETP	+11.8%	3,4 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 4 active · 11 ended

Active mandates

Hugues GENETTE

Mandate

Active

Jean-Charles GENETTE

Mandate

Active

Olivier GENETTE

Mandate

Active

Philippe GENETTE

Mandate

Active

Ended mandates

AVIXIA

Mandate · 0401.427.867

Represented by Philippe GENETTE

Ended

AVIXIA

Director · 0401.427.867

Represented by Philippe GENETTE

Ended

Hughes GENETTE

Director

Ended

Jean -Charles GENETTE

Director

Ended

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/09/2025	13/10/2024	21/11/2023	17/10/2022	29/09/2021	18/12/2020
General meeting	29/09/2025	03/10/2024	12/11/2023	14/10/2022	27/09/2021	12/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	29/09/2025	30/09/2025	French	PDF
Abridged model	31/12/2023	03/10/2024	13/10/2024	French	PDF
Abridged model	31/12/2022	12/11/2023	21/11/2023	French	PDF
Abridged model	31/12/2021	14/10/2022	17/10/2022	French	PDF
Abridged model	31/12/2020	27/09/2021	29/09/2021	French	PDF
Abridged model	31/12/2019	12/12/2020	18/12/2020	French	PDF
Abridged model	31/12/2018	27/11/2019	03/12/2019	French	PDF
Abridged model	31/12/2017	24/08/2018	30/08/2018	French	PDF
Abridged model	31/12/2016	17/11/2017	22/11/2017	French	PDF
Abridged model	31/12/2015	25/08/2016	31/08/2016	French	PDF
Abridged model	31/12/2014	13/08/2015	31/08/2015	French	PDF
Abridged model	31/12/2013	20/08/2014	29/08/2014	French	PDF
Abridged model	31/12/2012	20/11/2013	18/12/2013	French	PDF
Abridged model	31/12/2011	30/09/2012	30/11/2012	French	PDF
Abridged model	31/12/2010	01/06/2011	31/08/2011	French	PDF
Abridged model	31/12/2009	17/06/2010	30/08/2010	French	PDF
Abridged model	31/12/2008	18/06/2009	31/08/2009	French	PDF
Abridged model	31/12/2007	19/06/2008	08/01/2009	French	PDF
Abridged model	31/12/2006	30/06/2007	26/09/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 4 active · 11 ended

Active mandates

Hugues GENETTE

Mandate

Active

Jean-Charles GENETTE

Mandate

Active

Olivier GENETTE

Mandate

Active

Philippe GENETTE

Mandate

Active

Ended mandates

AVIXIA

Mandate · 0401.427.867

Represented by Philippe GENETTE

Ended

AVIXIA

Director · 0401.427.867

Represented by Philippe GENETTE

Ended

Hughes GENETTE

Director

Ended

Jean -Charles GENETTE

Director

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates16/05/2024
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DIVERS - DEMISSIONS, NOMINATIONS
PDF
Mandates31/12/2019
DEMISSIONS, NOMINATIONS
PDF
Mandates28/01/2015
DEMISSIONS, NOMINATIONS
PDF
Mandates31/12/2009
DEMISSIONS, NOMINATIONS
PDF
Mandates30/06/2006
SIEGE SOCIAL - DENOMINATION - ANNEE COMPTABLE - ASSEMBLEE GENERALE - CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 20242,4 k €↓
2023
Annual accounts 202314,3 k €↓
2022
Annual accounts 2022338,1 k €↑
2021
Annual accounts 2021-162,9 k €↓
2020
Annual accounts 2020227,1 k €↓
2019
Annual accounts 2019248,3 k €↑
2018
Annual accounts 2018153,2 k €↑
2017
Annual accounts 201756,2 k €↓
2016
Annual accounts 2016239,4 k €↓
2015
Annual accounts 2015331 k €↓
2014
Annual accounts 2014353,2 k €↑
2013
Annual accounts 2013333,8 k €↑
2012
Annual accounts 2012215,7 k €↓
2011
Annual accounts 2011282,9 k €↑
2010
Annual accounts 2010110,2 k €↑
2009
Annual accounts 20094,4 k €↓
2008
Annual accounts 200835,3 k €↑
2007
Annual accounts 200733,5 k €↑
2006
Annual accounts 2006-118,7 k €
16/07/2001
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMA MANUFACTURING

Overview

What does PHARMA MANUFACTURING do?

Trend over 19 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline